 MARSEILLE, France, Feb. 24, 2021 GLOBE NEWSWIRE -- Pursuant to the article L. 233-8 II of the French Code de Commerce and the article 223-16 of the French stock-market authorities Autorité des Marchés Financiers, or AMF General Regulation, Innate Pharma SA the Company - Euronext Paris: FR0010331421 IPH; Nasdaq: IPHA releases its total number of shares outstanding as well as its voting rights as of February 1, 2021: 